Dantrium and hypokalaemia Patient Reports February 13, 2012

Dantrium Side Effects Report #5809602-9
Dantrium side effect was reported by a Pharmacist from JAPAN on June 25, 2008. Female patient, 69 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with Dantrium. After drug was administered, patient experienced the following side effects: hypokalaemia. Dantrium dosage: 40 MG DAILY, IV NOS. During the same period patient was treated with CAPTOPRIL, NELBON, PAXIL. Patient was hospitalized. Patient recovered.

Dantrium Side Effects Report #5072945-3
Dantrium side effect was reported by a Physician from JAPAN on July 18, 2006. Male patient, weighting 17.64 lb, was diagnosed with cerebral palsy and was treated with Dantrium. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, fluid intake reduced, hepatic function abnormal, hypokalaemia, oral intake reduced, pyrexia, renal impairment, rhabdomyolysis, viith nerve paralysis. Dantrium dosage: unknown. During the same period patient was treated with NAUZELIN, TRICLORYL, LAC B, SOLDEM, ESCRE, MUCODYNE, HOKUNALIN, FERROMIA. Patient was hospitalized. Patient recovered.